MedTrace Logo

Diagnostic Accuracy of Quantitative Neuropad Test for Diabetic Peripheral Neuropathy

NCT05347420 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 600

Last updated 2022-04-26

No results posted yet for this study

Summary

This study aimed to evaluate the diagnostic vaule of quantitative Neuropad for diabetic peripheral neuropathy

Conditions

  • Diabetic Peripheral Neuropathy

Interventions

DIAGNOSTIC_TEST

The visual Neuropad test and the quantitative Neuropad test

The visual screening test includes whether the Neuropad test paper changes completely from blue to pink within 10 minutes (visual screening test a) and the time to complete color change (visual screening test b). the quantitative screening test using a handheld color scanner to scan the rate of color change, which estimated by the slope of the Neuropad color change per minute.

Sponsors & Collaborators

  • First Affiliated Hospital of Chongqing Medical University

    lead OTHER

Principal Investigators

  • Rong Li, PHD · First Affiliated Hospital of Chongqing Medical University

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-01
Primary Completion
2022-08-31
Completion
2023-08-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05347420 on ClinicalTrials.gov